Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burger

Showing results (651-660 of 1,123) with videos related to

Pageof 113
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|March 29, 2003
[Tuberculosis and HIV coinfection in three patients: the possibilities for simultaneous treatment]J J G van Oosterhout, M J Boeree, D M Burger, et al.
Der Urologe. Ausg. A|February 16, 2008
[Diagnosis of urothelial carcinoma]A Karl, D Zaak, D Tilki, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 29, 2017
Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoringLisa C Martial, Rob E Aarnoutse, Martina Mulder, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2026
Bictegravir concentrations in breastmilk of healthy, lactating women without HIVL C van der Wekken-Pas, E van Leeuwen, E W J van Ewijk-Beneken Kolmer, et al.
AIDS (London, England)|June 16, 2001
Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patientsP A Baede-van Dijk, P W Hugen, C P Verweij-van Wissen, et al.
Journal of Medicinal Chemistry|February 7, 2003
4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell linesGeoffrey Wells, Jane M Berry, Tracey D Bradshaw, et al.
Clinical Pharmacokinetics|November 7, 2024
Drug-Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for CliniciansDavid M Burger, Laura Nijboer, Mira Ghobreyal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 21, 2021
Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir: A Validation and Pharmacokinetic Simulation StudyLucas E Hermans, Monique Nijhuis, Hugo A Tempelman, et al.
Drug Safety|April 22, 2016
Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal ImpairmentElise J Smolders, Clara T M M de Kanter, Bart van Hoek, et al.
Virchows Archiv : an International Journal of Pathology|October 12, 2012
Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimensH M Fritsche, A Aziz, F Eder, et al.
Pageof 113

Showing results (651-660 of 1,123) with videos related to

Sort By:
Pageof 113
Nederlands Tijdschrift Voor Geneeskunde|March 29, 2003
[Tuberculosis and HIV coinfection in three patients: the possibilities for simultaneous treatment]J J G van Oosterhout, M J Boeree, D M Burger, et al.
Der Urologe. Ausg. A|February 16, 2008
[Diagnosis of urothelial carcinoma]A Karl, D Zaak, D Tilki, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 29, 2017
Dried Blood Spot sampling in psychiatry: Perspectives for improving therapeutic drug monitoringLisa C Martial, Rob E Aarnoutse, Martina Mulder, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2026
Bictegravir concentrations in breastmilk of healthy, lactating women without HIVL C van der Wekken-Pas, E van Leeuwen, E W J van Ewijk-Beneken Kolmer, et al.
AIDS (London, England)|June 16, 2001
Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patientsP A Baede-van Dijk, P W Hugen, C P Verweij-van Wissen, et al.
Journal of Medicinal Chemistry|February 7, 2003
4-Substituted 4-hydroxycyclohexa-2,5-dien-1-ones with selective activities against colon and renal cancer cell linesGeoffrey Wells, Jane M Berry, Tracey D Bradshaw, et al.
Clinical Pharmacokinetics|November 7, 2024
Drug-Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for CliniciansDavid M Burger, Laura Nijboer, Mira Ghobreyal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 21, 2021
Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir: A Validation and Pharmacokinetic Simulation StudyLucas E Hermans, Monique Nijhuis, Hugo A Tempelman, et al.
Drug Safety|April 22, 2016
Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal ImpairmentElise J Smolders, Clara T M M de Kanter, Bart van Hoek, et al.
Virchows Archiv : an International Journal of Pathology|October 12, 2012
Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimensH M Fritsche, A Aziz, F Eder, et al.
Pageof 113